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Abstract
There is growing evidence of cardiac complications due to corona virus disease 2019 (COVID 19). Our case is a case of
a young patient with COVID-19 and symptomatic sinus pauses.
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1. Introduction
ince the diagnosis of the ﬁrst case of corona
virus disease (COVID-19) in China in Dec
2019, the virus has spread rapidly, and declared
pandemic by WHO in March 2020. Respiratory
symptoms predominate the presentation because
the virus binds to ACE2 receptors through its
spike protein (S protein) after being activated by
trans-membrane protease serine 2 [1].
In a recent study of 138 patients who were hospitalized with COVID-19, approximately 16.7%
developed arrhythmia [2,3]. This is a case of a young
patient with COVID-19 and symptomatic sinus
pauses.
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2. Case Presentation
A 40 years old man with history of type II diabetes
mellitus and hypertension was presented to the
emergency department of our hospital with his ﬁrst
episode of syncope while having lunch followed by
another episode 1 h later. He did not have similar
episodes in past. He was having fever and dry cough
for the last three weeks. He had close contact with a
family member who is SARS-CoV-2 positive. His

reverse transcriptase polymerase chain reaction
(RT-PCR) test was positive on two occasions separated by 12 h. At home, he was taking metformin,
sitagliptin, and Irbesartan. He reported no use of
herbal supplements, illicit drugs, unusual dietary
consumption or alcohol use. He was not taking any
AV nodal blocking agents.
On arrival to the emergency department, his vitals
were as follows, heart rate 21 bpm, blood pressure
80/50 mmHg, respiratory rate 21/min, temp 36.5  C,
oxygen saturation 98% on room air. Physical examination including respiratory and cardiovascular
systems were unremarkable.
Electrocardiogram (ECG) showed long pauses
with ventricular escape rhythm (Fig. 1). He received
1 mg of atropine which temporarily increases his
heart rate to the 70s but soon his heart rate drifted
down, hence was started on dopamine infusion.
Following dopamine his ECG revealed normal sinus
rhythm at 65 b/min with right bundle branch block
(RBBB), left axis deviation, and left anterior fascicular block (Bifascicular block) (Fig. 2). Unfortunately, he had no previous ECG for comparison.
Bed-side temporary transvenous pacemaker was
inserted via left internal jugular vein under full
personal protective equipments with droplet
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precautions. The temporary pacemaker was kept at
VVI 40/min.
His chest X-ray which was done in supine position
with inadequate inspiration showed possible basal
consolidation.
His
laboratory
investigations
revealed high D-Dimer 1.18 ug/ml (N:0e0.5 ug/ml),
high ﬁbrinogen 5.05 g/L (N: 2e4 g/L), ESR 25, von
Willebrand factor (vWF) antigen 57% (N:50e160%),
CRP 16.76 mg/L (N:0e5 mg/L), Ferritin 731 ng/ml
(N:30e400 ng/ml), Troponin-I 0.12 ug/L (N:0e0.3
ug/L). There was mild neutropenia 37% (Normal
range 40e70%). His creatinine kinase and creatinine
kinase eMB, renal proﬁle, hemoglobin and platelets
were all normal. His NT-pro brain natriuretic peptide (NT-proBNP) was 44 pg/ml.
He was shifted from the emergency department to
an assigned COVID 19 ﬁeld intensive care unit
(FICU). He was treated with ceftriaxone intravenously and enoxaparin subcutaneously. His 2D
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Abbreviations
COVID 19
SERS COV 2
ACE 2
CHB

coronavirus disease 2019
severe acute respiratory syndrome
corona virus 2
Angiotensin converting enzyme 2
Complete heart block

ECHO was done within 48 hrs from the admission
and was completely normal. He used the pacemaker
brieﬂy in the ﬁrst 24 hrs but subsequently, he
maintained a stable rhythm throughout hospital
stay until discharge after 13 days. The temporary
pacemaker was removed on day four. He was
evaluated few weeks after discharge with 48 h
Holter which showed normal sinus rhythm
(maximum heart rate 116/min and minimum heart
rate 57/min with no pauses). His ECG was still

Fig. 1. ECG sinus pauses HR 21 b/min with ventricular escape rhythm.

Fig. 2. ECG e post Atropine and on dopamine infusion.
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showing bifascicular block. He underwent treadmill
exercise which was unremarkable.

3. Discussion
Although most patients with COVID-19 present
with mild respiratory illness, involvement of other
organs is common including the cardiovascular
system with manifestations that include myocardial
injury, myocarditis, and arrhythmias. Arrhythmic
complications from COVID-19 include various
forms of tachyarrhythmias and bradyarrhythmias.
One case report described the occurrence of asystole
in the setting of severe COVID-19 [4]. Cardiac
involvement with high troponin level is associated
with worse clinical outcomes.
The pathophysiology of cardiac involvement in
COVID-19 is multifactorial. It can result from direct
cardiotropic action of the virus mediated by angiotensin-converting enzymes inhibitor receptors
(ACE-2) which are expressed in various organs
including the cardiac myocites [5]. Cytokine storm
syndrome is an exaggerated systemic inﬂammatory
process that result from activation of various inﬂammatory markers including TNF (tumor necrosis
factor)-a, IL (interleukin)-6, MCP (monocyte chemoattractant protein)-1, G-CSF (granulocyte-colony
stimulating factor) and others [6]. This intense inﬂammatory response can affect various organs
including the heart and associated with high mortality. Inﬂammatory cells and SARS-CoV-2 virus
have been identiﬁed in the myocardium in autopsy
studies, suggesting direct invasion of the heart in
some cases [9].
Other theories that implicate cardiac involvement in COVID-19 include endothelial and coronary microcirculatory dysfunction resulting from
damage of the cardiac pericytes. Hypoxemia with
oxygen-demand mismatch, mediated by hypoxic
respiratory failure and increased metabolic demand is another mechanism by which the virus
can affect the heart, while hypercoagulable states
and plaque destabilization may result in coronary
events [7]. SARS-CoV-2 can affect various cardiac
ion channels leading to alteration in cardiac conduction and calcium handling which may predispose to arrhythmias [8].
It has been shown that atrial ﬁbrillation is the
commonest tachyarrhythmias reported, while sinus
bradycardia and complete heart block (CHB) are the
most common bradyarrhythmias reported [10].
Ventricular tachyarrhythmias and pulseless electrical activity are less commonly seen.
Our patient presented with syncope secondary to
signiﬁcant sinus pauses. Coronary artery ischemia

or myocarditis are not the cause of his presenting
arrhythmias as there was no history of chest pain.
His cardiac biomarkers were normal, and no evidence of ischemic changes in the ECG. Furthermore, his 2D ECHO revealed no regional wall
motion abnormalities with normal left ventricular
function. The mechanism of sinus pauses in this
case is suspected to be due to inﬂammatory
response based on high levels of D-dimers, CRP,
and Ferritin. With treatment his inﬂammatory
markers trended down and there was no recurrence
of pauses on follow up.

4. Conclusion
COVID-19 was initially considered solely to affect
the respiratory system leading to acute respiratory
distress. However, with time it became obvious that its
clinical spectrum expanded to involve other systems
like the cardiovascular system. Arrhythmic complications resulting from cardiac involvement are well
described. Most of the bradyarrhythmias reported as a
complication of COVID-19 are CHB. Signiﬁcant pauses are unusual presentation and are reported in the
setting of severe COVID-19 with evidence of myocardial injury. Our case is rare as the patient presented
with sinus pauses without risk factors for sinus node
dysfunction and was clinically and hemodynamically
stable during his hospital course with no evidence of
myocardial injury. His sinus pauses completely
resolved with treatment.
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